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ABSTRACT
Objective: This study was undertaken to examine the effect of successive pregnancies over a 3-year
period on the course of maternal human immunodeficiency virus (HIV) infection and the rate of
perinatal transmission ofHIV.
Methods: A retrospective analysis of 32 pregnancies in 14 known HIV-infected women vs. a
matched control group of HIV-infected women who had been pregnant only once was done.
Results: The multiple-pregnancy group was similar to the single-pregnancy group for age, race,
duration ofknown HIV infection, initial CD4 count, and date of first pregnancy. The delivery data
were similar as well. The CD4 counts in the multiple-pregnancy group fell from 595 to 460, while
counts in the single-pregnancy group fell comparably from 669 to 638, both over 37 months
(P 0.1476). Five of 5 second-born infants of known serostatus vs. 8 of 21 first-born infants were
HIV-infected (P < 0.05).
Conclusions: Successive pregnancies do not alter the course of HIV infection in asymptomatic
women followed up to 3 years. The infants of second pregnancies of known HIV-infected women
may be at higher risk for perinatal transmission. (C) 1995 Wiley-Liss, Inc.
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omen accounted for almost 15% of all new
diagnoses ofacquired immunodeficiency syn-
drome (AIDS) in the United States fromJune 1992
to July 1993. AIDS now represents the 5th leading
cause of death in women of reproductive age. In
light of this problem, multiple studies of the effect
of pregnancy on human immunodeficiency virus
(HIV)-infected women have been reported in re-
cent years. While most reports in this country have
concluded that pregnancy has minimal impact on
the progression of HIV infection,
2-6 others have
suggested an association with disease acceleration as
measured by CD4 counts or increased rates of ma-
ternal infectious diseases.
7-1 In addition, minimal
information exists concerning the effects of succes-
sive pregnancies on HIV-infected women, as most
such patients have been advised to consider steril-
ization in light of the presumed 20-25% risk of
perinatal transmission.
In communities where strong cultural or reli-
gious pressures against sterilization exist, many
women opt to proceed with subsequent pregnancies
after learning of their HIV infection. This report is
a retrospective analysis of several parameters used
to monitor disease progression, including CD4
counts, opportunistic infections, and deaths in a
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group ofwomen who have had successive pregnan-
cies after documentation of I-IIV infection vs. a
case-matched group of I-IIV-infected women who
have had only pregnancy over a similar time
period.
SUBJECTS AND METHODS
Nineteen women who had been pregnant more than
once since being diagnosed as HIV infected were
identified from the records of 191 HIV-seroposi-
tive women at the obstetrics clinic of the Medical
Center of Louisiana/Charity Hospital in New Or-
leans. All patients were delivered between January
1988 and October 1992. Of these, 14 had com-
plete records available for analysis. The study pa-
tients were matched case by case with I--IIV-infected
women who had been pregnant only once for age
(for year of birth), race, date of diagnosis of HIV
infection, date ofdelivery of first pregnancy, initial
CD4 count (measured during the first or second
trimester), and time since diagnosis of HIV infec-
tion. No patients with AIDS-defining illnesses prior
to pregnancy we’e included. Charts for the study
and control groups were retrospectively analyzed
for delivery data, CD4 counts prepartum and 3-7
weeks postpartum, risk factors for HIV infection,
evidence of opportunistic infections, maternal
deaths, use of antiretroviral drugs, and serostatus
of the child if known. The statistical analysis was
performed using an analysis of variance (ANOVA)
with repeated measures and Fisher’s exact test as
noted.
RESULTS
As previously stated, the individuals were case
matched for race (all were African American), age,
and months of follow-up after first delivery. There
were 32 total pregnancies in the study group (28
live births, 4 abortions). Five women in the study
group used zidovudine (ZDV) during pregnancy.
Three of these discontinued the drug in the first
trimester due to concern about potential adverse
fetal effects. One other used dideozyinosine (DDI)
and one used a blinded AIDS Clinical Trials Group
(ACTG) #076 study drug. In the control group, 7
women used ZDV during pregnancy, 3 of whom
discontinued the drug in the first or early second
trimester. One patient in the control group used a
blinded ACTG #076 study drug. Three women
from the study group and 4 from the control group
TABLE I. Progression of CO4 counts in
HIV-infected women’s successive pregnancies
Study group Control group
Initial CD4 count
Mean _+ SE 595 -+ 75 669 _+ 91 (NS)
Range 279-175 228-1,327
Final CO4
Mean _+ SE 460 _+ 40 (NS) 638 _+ 68
Range 260-790 345-1,290
"All values per mm3. NS not significant.
started antiretrovirals after pregnancy was diag-
nosed for maternal reasons. The timing and dosage
of the drugs varied widely.
The risk factors for HIV infection included
patient in the study group who had a history of
intravenous (IV)-drug abuse vs. 2 in the control
group. There were no patients with a history of
blood or blood-product transfusion; thus, the pre-
sumed mode of transmission in the remaining pa-
tients was heterosexual intercourse.
The delivery data were compared between the
study and control groups, including the rates of
chorioamnionitis, endometritis, low-birth-weight
infants, and type of delivery (cesarean vs. vaginal)
and found to be similar as well. There was case of
chorioamnionitis and endometritis in both the study
and control groups. Three low-birth-weight in-
fants (<2,500 g) were born in the study group vs.
2 among the controls, and there were 5 cesarean
deliveries in the study group vs. 3 among the con-
trols.
CD4 counts were also collected in both groups as
listed in Table 1. The differences in CD4 counts
between the study and control groups were not
significant at either the initial predelivery or the
final postdelivery determinations (P 0.15). In
addition, although mean CD4 counts fell in the
study group from 595/mm
3 to 460/mm3 over the
37-month period examined, the control group mean
fell from 669/mm to 638/mm at 37 months. This
difference was not significant as determined by
ANOVA with repeated measures (P 0. 1476).
The COg percents were similar as well. Due to the
wide variation in COg counts in this relatively small
analysis and the fact that COg counts do not follow a
standard distribution, the power in this analysis was
low (power 0.06).
Table 2 summarizes data on the serostatus of the
infants. An infected status was documented by viral
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TABLE 2. Status of children of HIV-infected mothers from successive pregnancies
HIV HIV
Total Deaths positive negative Indeterminate
Study group
First born 14 5 7
Second born 14 * 4* 0 9
Control group 14 0 2 6 6
*P < 0.05 (5/5 second-born HIV infected vs. 8/21 first-born of known serostatus).
cultures, polymerase chain reaction (PCR) deter-
mination, or AIDS-defining illness. Of interest,
all (5/5) of the second-born children whose statuses
were known were infected, including child who
died, vs. 8/21 first-born children (P < 0.05, Fish-
er’s exact test, power 0.65). However, in the
study group, the statuses of of the first-born
children and 9 of the subsequent children were
indeterminate. Among the controls, 6 children were
of indeterminate status.
DISCUSSION
Multiple alterations in immune status have been
reported to occur in pregnancy.
11-14 Several viral
illnesses other than HIV have been reported to have
increased associated morbidity in pregnancy as
well.
15-17 The hypothesis that HIV is similarly
more aggressive in pregnancy is suggested by stud-
ies showing a fall in CD4 counts, an apparent high
incidence of progression to clinical illness, and a
number of pregnancy-associated deaths. 7’8’18’9
These studies, however, are limited by either their
lack of control groups, small numbers, or large
numbers of IV-drug users with multiple concur-
rent problems being included in the study popula-
tion. Relatively little information using a control
group of nonpregnant infected women is available.
One such recent study found minimal differ-
ences in pregnant and nonpregnant women, exam-
2 ining both clinical and immunologic parameters.
A possible reason for the lack of nonpregnant con-
trol groups is that asymptomatic women at risk for
infection have not consistently undergone screening
for HIV until recently, in contrast to pregnant
patients, who frequently have more access to testing
and encouragement by health professionals.
The current study deals with this problem by
utilizing a control group of infected women who
had been pregnant once in comparison with women
who had had successive pregnancies since learning
they were infected. Due to a local cultural bias
against sterilization, many HIV-infected women in
this community decide to maintain their fertility.
More data on the long-term effects of successive
pregnancies on maternal HIV status and on the risk
of perinatal transmission would allow patients to
make better informed decisions regarding contra-
ception and sterilization.
These data suggest that successive pregnancies
following a diagnosis of HIV infection have mini-
mal effect on disease progression over a 3-year
follow-up period in previously asymptomatic
women. No opportunistic infections or AIDS-re-
lated deaths were seen; and, although differences in
CD4 counts were not significant, the low power in
this analysis does not rule out the possibility of a
type-II error. Furthermore, since all patients had
COg counts >200, no comment can be made re-
garding more severely affected patients. The use of
antiretroviral drugs cannot be assessed from these
data. The patients using antiretroviral drugs were
under the care of different physicians; therefore,
the doses and timing varied. Although the use of
ZDV has been shown to lessen the risk of perinatal
transmission in the recently closed ACTG #076
protocol, the maternal benefits of this drug in
asymptomatic patients with CD4 counts >200 are
uncertain,z
The data concerning the serostatuses of the in-
fants suggest that second-born infants are more
likely to be infected than first-born infants. Al-
though the factors affecting perinatal transmission
are poorly understood, it appears that low CD4
counts may correlate with a higher risk oftransmis-
sion. Whether the relatively small drop in CD4
counts (595 to 460) seen in the successive preg-
nancy group is sufficient to account for the higher
transmission rate in the second-born children is
unknown. Other factors suggested as possible trans-
mission risks such as low birth weight and chorio-
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amnionitis were infrequent and evenly distributed
among first and second births. The cesarean deliv-
ery rate was also similar (4/21 first born vs. 1/5
second born of known serostatus).
While deserving of further analysis, the in-
creased risk seen here should be viewed with cau-
tion due to the large number of indeterminate chil-
dren and relatively small sample. The decision to
delay or cease childbearing would likely be pro-
foundly affected if the children of successive preg-
nancies following HIV infection were shown to be
at significantly higher risk for perinatal transmis-
sion.
The current study did not attempt to document
the variables in prenatal care, precise timing of
maternal HIV infection, or risk behaviors in the
study and control groups, which may also influence
transmission. Moreover, many centers including
the current study site are now routinely using ZDV
in pregnant women based on the information from
ACTG #076. This routine will likely decrease
transmission overall, making comparison of pre-
and post-ZDV-u,se pregnancies difficult. A pro-
spective analysis of a sufficient number of infected
women at risk for successive pregnancies would be
necessary to determine the precise risk of HIV
transmission to subsequent children.
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